---

$7.89

N/A ( 0% ) 2.2K

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's lead drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2023-09-07	Sale	-112147.00	Ryan John L
2023-09-07	Sale	-180000.00	Aggarwal Gaurav
2023-08-30	Sale	-1355000.00	Gupta Pramod
2023-08-30	Sale	-4684775.00	Gupta Shalabh K.
2023-08-30	Sale	-570329.00	Townsend John
2023-08-30	Sale	-1355000.00	Jermasek Douglas